Clinical Trial Update: Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessing the pharmacokinetics and pharmacodynamics of basal continuous insulin infusion delivered intradermally or subcutaneously. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: COMPLETED